Literature DB >> 9718288

Effects of cotinine on cigarette self-administration.

D Hatsukami1, B Lexau, D Nelson, P R Pentel, M Sofuoglu, A Goldman.   

Abstract

Previous studies have shown that cotinine, a metabolite of nicotine, antagonizes some of the effects of nicotine. One study showed that cotinine eliminates the beneficial effects of the nicotine patch in reducing cigarette withdrawal symptoms. The purpose of this study was to examine the effects of various doses of cotinine on cigarette self-administration. Subjects were randomly assigned to one of three doses of cotinine fumarate (40, 80 and 160 mg) and placebo, each for a period of 10 days, in a randomized order. Outcome variables included measures of nicotine intake and subjective responses to smoked cigarettes. Results showed no differences in the number of cigarettes smoked, carbon monoxide levels, and weights of cigarette butts across the various doses of cotinine and placebo. However, higher nicotine serum levels were observed in the 160 mg cotinine fumarate condition compared to placebo and to 40 mg cotinine fumarate. No systematic effects of cotinine on subjective responses to cigarettes were observed. Cotinine appears potentially to have a selective modulatory effect on nicotine withdrawal symptoms but not on cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718288     DOI: 10.1007/s002130050661

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Developing and validating a human laboratory model to screen medications for smoking cessation.

Authors:  Sherry A McKee; Andrea H Weinberger; Julia Shi; Jeanette Tetrault; Sabrina Coppola
Journal:  Nicotine Tob Res       Date:  2012-04-06       Impact factor: 4.244

2.  Modeling the effect of alcohol on smoking lapse behavior.

Authors:  Sherry A McKee; Suchitra Krishnan-Sarin; Julia Shi; Tricia Mase; Stephanie S O'Malley
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

3.  The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment.

Authors:  Adriana Lori; Yilang Tang; Stephanie O'Malley; Marina R Picciotto; Ran Wu; Karen N Conneely; Joseph F Cubells
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

Review 4.  Developing human laboratory models of smoking lapse behavior for medication screening.

Authors:  Sherry A McKee
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

5.  Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice.

Authors:  Nathalie Alvarez-Ricartes; Patricia Oliveros-Matus; Cristhian Mendoza; Nelson Perez-Urrutia; Florencia Echeverria; Alexandre Iarkov; George E Barreto; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

Review 6.  Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder.

Authors:  Cristhian Mendoza; George E Barreto; Alexandre Iarkov; Vadim V Tarasov; Gjumrakch Aliev; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

Review 7.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

Review 8.  Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions.

Authors:  Xiaoying Tan; Kent Vrana; Zheng-Ming Ding
Journal:  Front Behav Neurosci       Date:  2021-10-21       Impact factor: 3.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.